Similar Search Results

Emotional labour and its consequences in health-care setting

Lazányi, Kornélia - Keleti Károly Gazdasági Kar, Óbudai Egyetem

The psychosomatic consequences of emotional labour are numerous. However, the most often debated one is burnout. Employers, through enforcing emotional norms onto employees expose their employees to emotional exhaustion, and in the long run depersonalization. Nevertheless, not all levels of...

Persistent link: https://www.econbiz.de/10008866062

Stakeholder perceptions of thoracic rapid tissue donation: An exploratory study

McIntyre, Jessica; Pratt, Christie; Pentz, Rebecca D.; … - In: Social Science & Medicine 99 (2013) C, pp. 35-41

) and clinic staff (n = 9) from the Thoracic Oncology Program at Moffitt Cancer Center, in Tampa, Florida, USA. All focus …

Persistent link: https://www.econbiz.de/10011042460

Testing devices or experimental systems? Cancer clinical trials take the genomic turn

Nelson, Nicole C.; Keating, Peter; Cambrosio, Alberto; … - In: Social Science & Medicine 111 (2014) C, pp. 74-83

contemporary clinical trials in oncology are not reducible to mere drug testing. Drawing on ethnographic fieldwork and interviews … with researchers in the field of oncology from 2010 to 2013, we introduce a conceptual contrast between trials as testing … biological or clinical insights. The rise of “biomarker-driven” clinical trials in oncology, which link measurable biological …

Persistent link: https://www.econbiz.de/10011042729

Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany

Ruof, Jörg; Knoerzer, Dietrich; Dünne, Anja-Alexandra; … - In: Health Policy 118 (2014) 2, pp. 242-254

marketing authorisation to those considered by G-BA in the field of oncology. …

Persistent link: https://www.econbiz.de/10011116913

The information content of the WTP-WTA gap: An empirical analysis among severely ill patients

Havet, Nathalie; Morelle, Magali; Penot, Alexis; … - Groupe d'Analyse et de Théorie Économique Lyon … - 2012

Large disparities between willingness to pay (WTP) and willingness-to-accept (WTA) are commonly encountered in empirical studies and raise some important controversies. Nevertheless, the relationships between WTA and WTP can help understand not only how a service is valued but also how it can be...

Persistent link: https://www.econbiz.de/10011031525

The economics of cancer care: longitudinal changes in provider efficiency

Langabeer, James; Ozcan, Yasar - In: Health Care Management Science 12 (2009) 2, pp. 192-200

Persistent link: https://www.econbiz.de/10005068247

Restraining High and Rising Cancer Drug Prices: Need for Accelerating R&D Productivity and Aligning Prices with Value

Bhardwaj, Ramesh - Volkswirtschaftliche Fakultät, … - 2015

ABSTRACT The high price of cancer drugs has become a world-wide phenomenon. In recent decades, studies have produced ample evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence that the current model of drug development needs...

Persistent link: https://www.econbiz.de/10011250913

Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation

Deconinck, Eric; Miadi-Fargier, Houda; Le Pen, Claude; … - Université Paris-Dauphine (Paris IX) - 2010

/refractory FL in France, with ICERs below those observed for other therapies in the oncology field. The cost of rituximab was partly …

Persistent link: https://www.econbiz.de/10010707184

Patient relevant endpoints in oncology : current issues in the context of early benefit assessment in Germany

Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health economics review 4 (2014) 2, pp. 1-8

, focusing on overall survival as the preferred endpoint in oncology. A taskforce of experienced German outcomes research … external stakeholders. Distinctive features of registration trials in oncology need to be considered when these studies form … clinical trial programs that were developed to be consistent with regulatory guidance, endpoints in oncology are thoroughly …

Persistent link: https://www.econbiz.de/10010528451

Whole exome sequencing in molecular diagnostics of cancer decreases over time : evidence from a cost analysis in the French setting

Bayle, Arnaud; Droin, N.; Besse, B.; Zou, Z.; Boursin, Y.; … - In: The European journal of health economics 22 (2021) 6, pp. 855-864

Persistent link: https://www.econbiz.de/10012586673